Targeting B-RAF Mutated Sarcomas

作者: Sarina Gouravan

DOI:

关键词: V600ECancer researchMutation (genetic algorithm)Personalized medicineCancerPathologyMedicineSarcoma

摘要:

参考文章(110)
Christopher D.M. Fletcher, Krisjnan Unni, Fredrik Mertens, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone IARC Press. ,(2002)
Jack McCain, The MAPK (ERK) Pathway: Investigational Combinations for the Treatment Of BRAF-Mutated Metastatic Melanoma P & T : a peer-reviewed journal for formulary management. ,vol. 38, pp. 96- 108 ,(2013)
Svetlana A. Protsenko, Anna I. Semionova, Yuri I. Komarov, Svetlana N. Aleksakhina, Alexandr O. Ivantsov, Aglaya G. Iyevleva, Evgeny N. Imyanitov, BRAF-mutated clear cell sarcoma is sensitive to vemurafenib treatment Investigational New Drugs. ,vol. 33, pp. 1136- 1143 ,(2015) , 10.1007/S10637-015-0280-0
Christoph Lengauer, Kenneth W. Kinzler, Bert Vogelstein, Genetic instabilities in human cancers Nature. ,vol. 396, pp. 643- 649 ,(1998) , 10.1038/25292
Richard Pazdur, Mark Rothmann, Donna Griebel, Ann Staten, Jogarao Gobburu, Atiqur Rahman, Gang Chen, Gabriel Robbie, Gene Williams, Martin Cohen, Ramzi Dagher, Approval Summary Imatinib Mesylate in the Treatment of Metastatic and/or Unresectable Malignant Gastrointestinal Stromal Tumors Clinical Cancer Research. ,vol. 8, pp. 3034- 3038 ,(2002)
Donald Wlodkowic, William Telford, Joanna Skommer, Zbigniew Darzynkiewicz, Apoptosis and beyond: cytometry in studies of programmed cell death. Methods in Cell Biology. ,vol. 103, pp. 55- 98 ,(2011) , 10.1016/B978-0-12-385493-3.00004-8
Jacques Ferlay, Isabelle Soerjomataram, Rajesh Dikshit, Sultan Eser, Colin Mathers, Marise Rebelo, Donald Maxwell Parkin, David Forman, Freddie Bray, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. ,vol. 136, ,(2015) , 10.1002/IJC.29210
Wynand P. Roos, Steve Quiros, Andrea Krumm, Stephanie Merz, Olivier Jérôme Switzeny, Markus Christmann, Carmen Loquai, Bernd Kaina, B-Raf inhibitor vemurafenib in combination with temozolomide and fotemustine in the killing response of malignant melanoma cells Oncotarget. ,vol. 5, pp. 12607- 12620 ,(2014) , 10.18632/ONCOTARGET.2610
S. Kopetz, J. Desai, E. Chan, J. R. Hecht, P. J. O'Dwyer, R. J. Lee, K. B. Nolop, L. Saltz, PLX4032 in metastatic colorectal cancer patients with mutant BRAF tumors. Journal of Clinical Oncology. ,vol. 28, pp. 3534- 3534 ,(2010) , 10.1200/JCO.2010.28.15_SUPPL.3534
Heiko Kuip, Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec®, Gleevec™) Therapeutics and Clinical Risk Management. ,vol. 4, pp. 163- 187 ,(2008) , 10.2147/TCRM.S1527